Infinity Medical Research

North Dartmouth, Massachusetts MA 2747

2 studies enrolling now · 17 studies all time

What they study most

Asthma, Cataplexy, Dyslipidemia, Excessive Daytime Sleepiness, Hypercholesterolemia, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, Interstitial, Narcolepsy, OSA, Obesity, Overactive Bladder

Studies at this site

• Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF) — Recruiting now
• Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis — Stopped early
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea — Running, not enrolling
• A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) — Completed
• Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) — Completed
• Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) — Completed
• A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma — Completed
• Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) — Paused
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
• Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity. — Completed
• A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma — Completed
• Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy — Completed
• A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale — Completed
• A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins — Completed
• A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine — Completed